Introduction
In the last decade the expert's attention to the significance that oral health can have in atherosclerosis is raising. Cardiovascular diseases are secondary to atherosclerosis. Within cardiovascular diseases, heart related ones are noted. Ischemic cardiomyopathy is the most important sign that defines coronary artery disease (1, 2). Nowadays, heart diseases are the major cause of death in developed countries (1). The classic risk factors related to these diseases have been identified as age, sex, heredity, diet, diabetes, high blood pressure, exercising and smoking. At present many studies show that inflammatory diseases with a chronic basis increase the risk of suffering from cardiovascular diseases. This is the reason why within the past decades researches on chronic infections effects on coronary pathogenesis have increased (3-6). The mechanism whereby chronic infections increase the risk of suffering atherosclerosis or thrombosis is unclear, nonetheless it is believed that the requirement is a longterm systemic exposure to the pathogens (7) (8) (9) (10) (11) (12) (13) (14) (15) . A periodontal disease causes a sort of chronic inflammation (3) which provides bacteria and their components a direct access to the bloodstream, to which is added the micro ulceration of the epithelium of the periodontal pocket (4, 16, 17) . The contact between germs and macrophages causes a direct release of pro-inflammatory mediators TNFα) , that facilitates the attraction of neutronphils from vessels (innate immunity). The FNTα favors increased hepatic synthesis of LDL cholesterol. Equally, IL-6 is released later which helps the production of C-reactive protein (CRP) in the liver. This fact accellerates the atherosclerosis plaque progression. Thereby, it seems that periodontal diseases could be an additional factor for the atherosclerosis development. Nevertheless, not all studies have stated that they have found causality, owing to the multi-factorial nature of both dental infection and cardiovascular disease and to the confusion factors adjustment that should be considered in every study. The primary aim of this review was to analyze the assumed connection between periodontitis and cardiovascular diseases. In this respect the analysis has been focused on the relevance of periodontal germs as a cardiovascular risk factor.
Material and methods
A research was carried out at Medline/Pubmed (http:// medline.cos.com) with the following keywords: oral pathogens OR Actinobacillus actinomycetemcomitans OR Porphyromonas gingivalis AND cardiovascular disease. Taken in criteria and research method: The articles selection has been made taking into account key-words either in the title or in the summary. Experimental studies in animals, clinical prospective studies performed with a minimum sample size (>30) and studies written in English have been included. Clinical retrospective studies, studies carried out with a low sample size (n<30) and non English language written studies were rejected.
Literature review
In the last decade, many epidemiological studies have brought to light that oral infections, especially PD, can act as independent risk factor for several systemic diseases, like the CVD. It has been argued that mediators of inflammation in PD are the same involved in other chronic diseases such as CVD. The cause-effect relationship between the two processes is being studied with great interest (1). Inflammations appear to play a significant role in the pathogenesis of atherosclerosis. Low-grade chronic inflammatory processes could be involved in the development of this course. The PD is caused by a chronic infection associated with elevated CRP and other inflammatory biomarkers.
Histopathology and pathophysiology of atherosclerosis by periodontal inflammation: etiopathogenic models
When there is an initial damage of the endothelium, endothelial cells generate adhesion molecules called vascular cell adhesion molecules (VCAM) and intercellular adhesion molecules (ICAM) (1, 16, 17) . As a result the endothelium starts being attacked by leukocytes. Endothelial permeability to lipids (LDL cholesterol) increases, and production of cytokines/chemokines is enhanced as well as growth factors that at the same time stimulate monocytes/macrophages. Cytokines boost the attraction of polymorphonuclear cells (PMN) (2) as well, and the migration of smooth muscle cells, which respond to inflammatory stimuli by the secretion of metalloproteinases that are capable to degrade elastin and collagen (18, 19) . Thereby, the fibrous capsule that maintained the plaque attached to the artery wall can break and detach, increasing in this way the risk of thrombosis, embolisms and strokes. Atherosclerosis is a chronic inflammatory disorder characterized by the accumulation of monocytes/macrophages, lipids (LDL cholesterol), smooth muscle cells and lymphocytes within the arterial wall in response to the release of pro-inflammatory molecules. Thus, the host immune system plays an essential role in the development of the atherosclerotic plaque. This can be stimulated by certain molecules of the host, such as oxidized low-density lipoprotein (oxLDLs), lipoprotein a (Lpa) or foreign antigens, including the ones of certain bacteria (7).
Oral pathogens in atheromatous plaque
The most typical oral pathogens associated with human PD are Porphyromonas gingivalis (Pg), Actinobacillus actinomycetemcomitans (Aa) and Streptococcus sanguis (Ss), which can all invade the junctional epithelium and gain access to the systemic circulation. Possible mechanisms by which oral pathogens can contribute to CVD are by a direct effect on the formation of e478 J Clin Exp Dent. 2011;3(5):e476-82.
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CVD (by a direct effect). The Pg possesses numerous virulence factors such as proteases, lipopolysaccharides, capsular polysaccharides, hemagglutinins and fimbriae (12). In vitro studies have shown that the fimbriae of this microorganism plays a pivotal role in the invasion and adhesion to endothelial cells (10), in stimulating the production of cell adhesion molecules (VCAM) and the expression of chemokines (13). In addition, the Pg is a producer of proteases that can activate platelet aggregation and stimulate the coagulation cascade. Thereby it contributes to the disruption of the atherosclerotic plaque and thrombotic complications (1, 10). Platelet receptors have been described for a PG antigen (14). This fact would determinate their aggregation, the capability of some periodontal pathogens to invade the endothelium and their DNA presence at the atheromatous plaque. Lourbakos et al. (14) found an association between Pg and the atherosclerotic plaque in the endothelium; by an indirect effect mediated by the host immune response (5); or by a genetic predisposition for pathogenesis (1). Some academics found a causal relationship between PD and CVD. They support the etiopathogenic model in which periodontal bacteria such as Aa and Pg, once in the bloodstream (bacteremia), would stimulate by an indirect effect the release of antibodies (5), cytokines and other pro-inflammatory mediators such as CRP or TNFα (6). They would be responsible for initiating a cascade of biochemical reactions, causing endothelial damage and ultimately facilitating the genesis of the atherosclerotic plaque (1).
Other studies have pointed out the presence of Pg at the atheromatous plaque (3, (7) (8) (9) (10) (11) CVD through the production of a proteinase (argininegingipains) that can activate protease receptors PAR-1 and PAR-4 which are evidenced on the platelet surface. In a recent study, Roth et al. (11) discussed for the first time the capability of the Pg to invade smooth muscle cells of blood vessels and modulate the production of the Tissue Factor (TF) and its inhibitor (TFPI). They found that the Pg was able to decrease the production and activity of TFPI and enhance the production and activity of TF. They noticed that this periodontal pathogen has prothrombotic effects by acting on smooth muscle cells, modulating the production TFPI. From another clinical study emerged that hemagglutinins are involved in the adhesion of Pg to endothelial cells of human coronary arteries (15) .
Experimental studies on animals
Experimental studies have been useful to clarify the pathogenic models of bacterial action on atherogenesis. Some in vivo studies on animals (10, 13, 20, 22) discovered that individuals who were inoculated periodontal microorganisms had more advanced and larger atherosclerotic lesions, which were developed before, than the animals from the control group. Genco et al. (2) suggested that Pg infection, which is one of the most important pathogens associated with human PD, activates the acute response of systemic inflammation, increases lipaemia and enhances atherosclerotic lesion formation in ApoE (+/-) mice (heterozygous genotype). Chi et al. (18) observed on their experimental study on mice that interleukin 1 (IL-1) promotes atherogenesis. This is due to the analysis of post-mortem atheromatous plaque samples, which indicated that mice without IL-1 receptor (ApoE +/-/IL-1R1 -/-) had smaller atheromatous lesions than ApoE +/-/IL-1R1 +/-mice. Madan et al. (19) experimented about ApoE (+/-) mice as well. They found that ApoE +/-/IL-6 -/-mice had a significant increase on the aortic atheromatous lesions, higher levels of acute coronary syndrome (ACS) and pro-inflammatory cytokines compared with ApoE +/-/IL-6 +/-group. These results insinuate that IL-6 has a protective function against atherosclerosis. Miyamoto et al. (17) became aware of more advanced atheromatous damages at hyper-lipemic mice. In addition, Brodala et al. (20) detected Pg DNA at atheromatous plaques on carotid and aortic artery vascular tissues in pigs. These animals were given a high-fat diet and were inoculated a Pg infection. Bacteremia by Pg induced atherosclerosis in pigs with normal cholesterol levels, and increased atherosclerosis in pigs with high cholesterol levels. It seemed that PD enhanced the accumulation of lipids in vivo, due to chronic inflammation. Therefore, it is believed that the infectious agent by itself does not cause atherosclerosis, but it does contribute to accelerate its progression when this damage is already formed (21). In another study on animals (13), the experts checked also that immunization (vaccination) against Pg prevents the atherosclerosis acceleration. However, not all the studies proof finding this causality. Miyamoto et al. (17) for instance, could not demonstrate during their experimental study on mice that infection by Pg could cause an important systemic inflammatory reaction. They studied the levels of IL-6 and Amyloid A (the equivalent of CRP in humans) on serological samples of Pg infected and non-infected mice, and they found very similar levels on both groups.
Clinical studies on humans
Several clinical studies on humans reveal that some pathogens of bacterial plaque have a direct effect on atherosclerosis even though some study designs are more appropriate than others when it comes to look for the causality relation between PD and CVD (Table 1) . Meurman et al. (1) summarize on their literature review the necessary criteria to establish the causality between these phenomena (PD-CVD) ( Table 2) . IgG antibody measurement is one of the most used factors with the aim of setting a causal link between PD and atherosclerosis. In some studies they took samples from sub-gingival biofilm and made a serologic analysis, in which they detected antibodies against periodontal pathogens (3, 5, (22) (23) (24) . An association between these pathogens and atherosclerosis (coronary disease specifically) was found after adjusting other risk factors for CVD. However, this fact could not prove a cause-effect relation. Pussinen et al. (5) , on their transversal cohort study, found a link between IgG against Pg and Aa, and ischemic cardiopathy (IC). They noticed greater prevalence of IC in those subjects with high IgG levels than in those with low levels. They related edentulism and seropositivity to Pg with IC. With lineal regression, they observed that the antibody reaction was associated directly with the prevalence of IC. Sakurai et al. (16) thought that Aa could play a determinant role in the development of acute coronary syndrome (ACS). This is because they found Aa at the oral plaque samples taken from subjects with ACS. Contrastingly, the counts were negative in subjects who suffered chronic ischemic cardiopathy (CIC). Demmer et al. (25) , in a very recent cohort prospective study, analyzed the periodontal infection as a risk factor for CVD, by the study of periodontal clinical parameters, using them as a substitute for the underlying bacterial exposure. They found that the periodontal clinical measures which demonstrated greater link with bacteria charges were: rate of bleeding points after probing (r=0.62); number of locations with bleeding after probing (r=0.59) and rate of locations with probing depth (PD) ≥ 3 mm (r=0.61), whereas PD ≥ 8 mm, r=0.16. This fact could demonstrate that the clinical definition for PD should include the low-depth periodontal pocket measue480 J Clin Exp Dent. 2011;3(5):e476-82. Periodontal microorganisms as a risk factor for heart disease.
res in order to show better the relationship between PD and bacteria rates. Pussinen et al. (6) carried out a cohort prospective study with a sample of 6,051 participants with the aim of relating serologic endotoxins, IgG against periodontal pathogens and inflammation markers (IL-6, CRP) in relation with CVD. They took samples of endotoxins and serologic antibodies from 784 collaborators. High levels of endotoxins were related positively with diastolic pressure, total cholesterol, body mass index (BMI) and IgG against Pg. During ten years of monitoring, they realized that those individuals who suffered any episode of CVD had higher blood levels of endotoxins. High concentration of endotoxins, antibodies, CRP and IL-6 are directly associated with cardiovascular episodes when adjusted by age and gender. They came to the conclusion that high IgG levels against Aa and Pg could be considered as a cardiovascular risk factor in the future, researchers studied people who had suffered myocardial infarction (MI), and they found a serological evidence of an association with PD (4). In another cohort prospective study (6) the atheromatous plaques of 51 patients, which had to be operated surgically, were analyzed. The presence of 5 microorganisms come into view in both the atheromatous plaque of the coronary arteries and the subgingival plaque: Aa, Pg, Bacteroides forsythus, Treponema denticola and Campylobacter rectus. Therefore, PD was related directly to the detection of periodontal bacteria DNA in atheromatous lesions. The DNA identification of those pathogens at the atheromatous plaque was carried out with polymerase chain reaction (PCR), immunofluorescence and electronic microscopy techniques (3, 8).
It seems that atherosclerosis is an inflammatory nature disease more than a disease caused by an excess in lipid deposit. Equally, PD is a consequence of the host inflammatory reaction more than a direct destruction from the pathogens infection. It has been observed that chronic infections cause possible bacteremia which lead to the attack and activation of endothelial cell inflammation caused by periodontal pathogens as Pg. The studies accomplished, however, have not been able to isolate viable bacteria, but just their sequence of nucleic acids. This supports the evidence that chronic infections help generate a modification in the regulation of the inflammatory response. This in turn provokes a further alteration of endothelial cells on the one hand and acceleration in the formation of atheromatous plaques on the other (26). In PD there would be an over regulation of certain inflammation markers such as CRP or soluble E-selectin. By reducing these bio-markers and controlling local and systemic inflammation, endothelial dysfunction and the risk of CVD would decrease (26, 27) . At the vessel wall, after endothelial injury, monocytes and lymphocytes migrate into the blood vessel wall, led by inflammation signs. Then monocytes differ into macrophages, which recognize and phagocytose LDLcholesterol particles. These monocytes, process and pre- 
Discussion
CVD is the most common cause of death in developed countries. The classic factors that predispose to CVD are identified: dyslipidemia, genetics, age, gender, high blood pressure, smoking, diabetes mellitus and metabolic syndrome. Obvious risk factors for CVD such as obesity and stress also appear to be related to PD. However, we must consider the emerging risk factors as biological markers: homocysteine, atherogenic lipoproteins, CRP and fibrinogen. These two factors reflect the levels of low intensity chronic systemic inflammation, as in the case of PD. This could be related to an increased risk of CVD (4-6). In fact, the PD-CVD association has been one amidst the most studied in recent years (7). However, this link is difficult to prove because both diseases share common risk factors (age, gender, smoking, oral hygiene habits or diabetes mellitus). In previous reviews on the subject, some experts (1, 2) warned of the need to be cautious when affirming a causal relationship between PD-CVD, due to the difficulty of drawing conclusions based on the results of the studies reviewed . Besides, there are confounding factors that may not have been taken into consideration in certain clinical studies included in this review. In addition, the criteria for CVD and the diagnostic parameters for PD for each study could be different. The determination of bacterial species, bacterial proteins and lipopolysaccharide in the atheromatous plaques which block coronary arteries has raised speculation about the origin of these bacteria and what their reservoir is, finding that one of the possible places is the periodontal pocket (16). It has been observed that the distribution of periodontal pathogens in the gingival biofilm is closely related to the levels of antibodies against these bacteria in blood (5).
Periodontal bacteria would enter the bloodstream through the micro ulceration of the epithelium of the periodontal pocket. This entails a long-term systemic exposure of these pathogens. Once in the general circulation, they could play a direct or indirect role in the progression of atherosclerotic plaques in arterial lesions (16). The antiinfective periodontal therapies, not only improve the clinical symptoms, but also improve local antioxidant status and systemic vascular endothelial dysfunction (28). This was evident in experimental studies. As such by inoculating periodontal bacteria they observed greater vascular lesions. Through the increase of blood lipids systemic inflammation activates atherogenesis. This is the reason why periodontal diseases could enhance the accumulation of lipids and thus generate chronic inflammations. The infectious agent by itself does not cause atherosclerosis, but seems to help accelerate its progression when the lesion is formed (12) (13) (14) .
In clinical studies, one of the methods used to validate the association between periodontal bacteria and the atheromatous plaque has been the detection of antibodies against periodontal micro-organisms (5). Bacterial endotoxin and inflammatory mediators in relation to atheromatous lesions have been detected as well. In addition, the DNA of microorganisms present in the bacterial plaque and in the atheromatous lesion has been directly identified. Finally, scientists have tried to relate directly the level of clinical periodontal lesions (bleeding and pocket depth) with the level of inflammation and cardiovascular injury (25). There is plenty of epidemiological evidence with the data provided to date. This seems to confirm the role of periodontal damage by oral pathogens as a factor in the development of atherosclerosis. Yet, the quantification of this association remains unknown.
